Document is current
Any future updates will be listed below
-
Authors
Benussi, Alberto
Ashton, Nicholas J.
Karikari, Thomas K.
Alberici, Antonella
Saraceno, Claudia
Ghidoni, Roberta
Benussi, Luisa
Zetterberg, Henrik
Blennow, Kaj
Borroni, Barbara https://orcid.org/0000-0001-9340-9814
- License Information
-
More Information
Article History
Received: 15 August 2021
Accepted: 4 November 2021
First Online: 15 November 2021
Declarations
:
: Full written informed consent was obtained from all subjects according to the Declaration of Helsinki. The Brescia Ethics Committee approved the study protocol.
: Not applicable.
: HZ has served at scientific advisory boards for Eisai, Denali, Roche Diagnostics, Wave, Samumed, Siemens Healthineers, Pinteon Therapeutics, Nervgen, AZTherapies and CogRx, has given lectures in symposia sponsored by Cellectricon, Fujirebio, Alzecure and Biogen and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program (outside submitted work). KB has served as a consultant, at advisory boards, or at data monitoring committees for Abcam, Axon, Biogen, JOMDD/Shimadzu. Julius Clinical, Lilly, MagQu, Novartis, Roche Diagnostics and Siemens Healthineers and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program.
